Cargando…

Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease

It can be challenging for healthcare professionals (HCPs) to prescribe inhaled therapy for patients with chronic obstructive pulmonary disease (COPD) because of the multiple individual and combinations of inhaled medications available in numerous delivery systems. Guidance on the selection of an inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahler, Donald A., Halpin, David M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Focused Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559134/ https://www.ncbi.nlm.nih.gov/pubmed/37499210 http://dx.doi.org/10.1513/AnnalsATS.202304-384CME

Ejemplares similares

Defining Disease Modification in Chronic Obstructive Pulmonary Disease
por: Halpin, David M.G., et al.
Publicado: (2009)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Precision medicine in chronic obstructive pulmonary disease
por: Halpin, David M.G.
Publicado: (2022)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
por: Ohar, Jill A, et al.
Publicado: (2022)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G.
Publicado: (2018)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm
por: Wilkie, Morven, et al.
Publicado: (2015)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective
por: Chan, Amy H. Y., et al.
Publicado: (2021)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2017)

The Nurse Practitioners' Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease
por: Scullion, Jane
Publicado: (2018)

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
por: D’Urzo, Anthony, et al.
Publicado: (2015)

Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease
por: Aaron, Shawn D., et al.
Publicado: (2019)

An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
por: Çakmaklı, Seçil, et al.
Publicado: (2023)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial
por: Thompson, Philip J., et al.
Publicado: (2022)

Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting
por: Yawn, Barbara P, et al.
Publicado: (2012)

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

Prevention and control of influenza in persons with chronic obstructive pulmonary disease
por: Plans-Rubió, Pedro
Publicado: (2007)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future
por: Miravitlles, Marc, et al.
Publicado: (2018)

Clinical effectiveness of the Respimat(®) inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
por: Ram, Felix SF, et al.
Publicado: (2011)

Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease
por: Jakobsson, Jonas K F, et al.
Publicado: (2018)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
por: Lineros, Rosario, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?
por: AI-Kassimi, Faisal A., et al.
Publicado: (2013)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

Easyhaler(®): an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
por: Lavorini, Federico
Publicado: (2019)

Nanocrystals based pulmonary inhalation delivery system: advance and challenge
por: Yue, Pengfei, et al.
Publicado: (2022)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
por: Tashkin, Donald P
Publicado: (2020)

Inhaled Corticosteroids Selectively Alter the Microbiome and Host Transcriptome in the Small Airways of Patients with Chronic Obstructive Pulmonary Disease
por: Yip, William, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kpsj8gpaoje51jnhah6h7u5vph